The Mechanism of DNA Methylation and miRNA in Breast Cancer
International Journal of Molecular Sciences · 27.05.2023 · 24 (11) · 9360
DOI: 10.3390/ijms24119360 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 27.05.2023. Verfasst von Lingyuan Ma und 10 weiteren Autor:innen. Beteiligte Einrichtung: Lab of Biochemistry & Molecular Biology, School of Life Sciences, Yunnan University, Kunming 650091, China. Hauptthemen laut MEDLINE: MicroRNAs, Breast Neoplasms. Die Arbeit wurde bisher 71-mal zitiert (Crossref) und nennt 129 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the National Natural Science Foundation of China, the Youth Project of Science and Technology Department of Yunnan Province, the Key Project of Science and Technology Department of Yunnan Province.
Abstract (Originalsprache)
Breast cancer is the most prevalent cancer in the world. Currently, the main treatments for breast cancer are radiotherapy, chemotherapy, targeted therapy and surgery. The treatment measures for breast cancer depend on the molecular subtype. Thus, the exploration of the underlying molecular mechanisms and therapeutic targets for breast cancer remains a hotspot in research. In breast cancer, a high level of expression of DNMTs is highly correlated with poor prognosis, that is, the abnormal methylation of tumor suppressor genes usually promotes tumorigenesis and progression. MiRNAs, as non-coding RNAs, have been identified to play key roles in breast cancer. The aberrant methylation of miRNAs could lead to drug resistance during the aforementioned treatment. Therefore, the regulation of miRNA methylation might serve as a therapeutic target in breast cancer. In this paper, we reviewed studies on the regulatory mechanisms of miRNA and DNA methylation in breast cancer from the last decade, focusing on the promoter region of tumor suppressor miRNAs methylated by DNMTs and the highly expressed oncogenic miRNAs inhibited by DNMTs or activating TETs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Lab of Biochemistry & Molecular Biology, School of Life Sciences, Yunnan University, Kunming 650091, China.
- Yunnan Collaborative Innovation Center for Plateau Lake Ecology and Environmental Health, Kunming 650214, China.
Förderung
- the National Natural Science Foundation of China
- the Youth Project of Science and Technology Department of Yunnan Province
- the Key Project of Science and Technology Department of Yunnan Province
- the Project of Graduate Research Innovation of Yunnan University
- National Natural Science Foundation of China
- Yunnan Provincial Science and Technology Department
- Youth Project of Science and Technology Department of Yunnan Province
- Key Project of Science and Technology Department of Yunnan Province
Zitieren
APA
Ma, L., Li, C., Yin, H., Huang, J., Yu, S., Zhao, J., Tang, Y., Yu, M., Lin, J., Ding, L., & Cui, Q. (2023). The Mechanism of DNA Methylation and miRNA in Breast Cancer. International Journal of Molecular Sciences, 24(11), 9360. https://doi.org/10.3390/ijms24119360
Vancouver
Ma L, Li C, Yin H, Huang J, Yu S, Zhao J, et al. The Mechanism of DNA Methylation and miRNA in Breast Cancer. International Journal of Molecular Sciences. 2023;24(11):9360. doi:10.3390/ijms24119360
BibTeX
@article{Ma2023,
author = {Ma, Lingyuan and Li, Chenyu and Yin, Hanlin and Huang, Jiashu and Yu, Shenghao and Zhao, Jin and Tang, Yongxu and Yu, Min and Lin, Jie and Ding, Lei and Cui, Qinghua},
title = {The Mechanism of DNA Methylation and miRNA in Breast Cancer},
journal = {International Journal of Molecular Sciences},
year = {2023},
volume = {24},
number = {11},
pages = {9360},
doi = {10.3390/ijms24119360}
}
EUVIMED